Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Early diagnosis and treatment, like topical minoxidil, can prevent hair loss in children.

QR 678 and QR678 Neo treatments are effective for hair loss in women with PCOS.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.

PCOS affects nearly 25% of female medical and dental students, impacting their academic and social lives.

Flaxseed crackers can help reduce symptoms of PCOS in young women.

A holistic approach, including lifestyle changes and surgery, is recommended for better long-term PCOS management.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

Hirsutism can lower a woman's quality of life, causing emotional distress and affecting social and work opportunities.

Estradiol-rich plasma can increase hair density faster and more effectively in male pattern baldness treatment than regular plasma.

Reduced sexual drive may be linked to male breast cancer, while anti-estrogenic factors might lower the risk.

PCOS symptoms vary by age, affecting diagnosis and treatment.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Finasteride helps induce ovulation in nonresponder PCOS women.